Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Not Confirmed
Not Confirmed
26-29 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Industry Trade Show
Not Confirmed
26-29 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

17 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/17/3168567/0/en/Vor-Bio-Announces-Late-Breaking-Oral-Presentation-of-China-Phase-3-IgA-Nephropathy-Clinical-Study-at-American-Society-of-Nephrology-s-Kidney-Week-2025.html

16 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/16/3167846/0/en/Vor-Bio-Announces-Publication-of-China-Phase-3-Study-of-Telitacicept-in-Systemic-Lupus-Erythematosus-in-The-New-England-Journal-of-Medicine.html

14 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/2025-acr-abstract-released-exciting-data-from-telitacicepts-phase-iii-clinical-study-in-sjogrens-syndrome-in-china-302582947.html

29 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/29/3157572/0/en/Vor-Bio-Announces-Late-Breaking-Poster-Presentation-of-Phase-3-Primary-Sj%C3%B6gren-s-Disease-Clinical-Study-at-ACR-Convergence-2025.html

17 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/17/3152015/0/en/Vor-Bio-Announces-Oral-Presentation-of-48-Week-China-Phase-3-Generalized-Myasthenia-Gravis-Clinical-Study-at-AANEM.html

28 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/remegen-vor-bio-score-again-telitacicept-time-igan
ABOUT THIS PAGE